Cargando…

Antihypertrophic actions of NO-independent soluble guanylyl cyclase (sGC) ligands BAY 41-2272 and BAY 58-2667 in vitro

Detalles Bibliográficos
Autores principales:	Ritchie, Rebecca, Irvine, Jennifer, Love, Jane, Horowitz, John, Stasch, Johannes-Peter, Kemp-Harper, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313373/ http://dx.doi.org/10.1186/1471-2210-9-S1-P59

Ejemplares similares

Relaxant effect of BAY 41-2272 and BAY 58-2667 in the gastrointestinal tract of apo-sGC mice
por: Cosyns, Sarah, et al.
Publicado: (2011)

The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
por: Irvine, Jennifer C., et al.
Publicado: (2012)

NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272
por: Becker, Eva Maria, et al.
Publicado: (2001)

The soluble guanylyl cyclase stimulator BAY 41-2272 increases differentiation and function of brown adipocytes
por: Etzrodt, Jennifer, et al.
Publicado: (2013)

BAY 58-2667, an NO-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts
por: Krieg, Thomas, et al.
Publicado: (2009)

Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
por: Radovits, Tamás, et al.
Publicado: (2009)

The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems
por: Vandendriessche, Benjamin, et al.
Publicado: (2013)

The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems
por: Vandendriessche, Benjamin, et al.
Publicado: (2013)

Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
por: Frey, Reiner, et al.
Publicado: (2011)

Mapping of the sGC Stimulator BAY 41-2272 Binding Site on H-NOX Domain and Its Regulation by the Redox State of the Heme
por: Makrynitsa, Garyfallia I., et al.
Publicado: (2022)

The nitroxyl donor isopropylamine-NONOate elicits soluble guanylyl cyclase-dependent antihypertrophic actions: comparison of the potential therapeutic advantages of HNO over NO•
por: Ritchie, Rebecca, et al.
Publicado: (2013)

BAY 41-2272 Attenuates CTGF Expression via sGC/cGMP-Independent Pathway in TGFβ1-Activated Hepatic Stellate Cells
por: Chen, Po-Jen, et al.
Publicado: (2020)

The sGC stimulator BAY 41-8543 in a rat model of hypertension-induced heart failure
por: Haase, N, et al.
Publicado: (2015)

Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension
por: Amirjanians, Matthieu, et al.
Publicado: (2017)

Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
por: Scheerans, Christian, et al.
Publicado: (2011)

Comparative Studies of the Dynamics Effects of BAY60-2770 and BAY58-2667 Binding with Human and Bacterial H-NOX Domains
por: Rehan Khalid, Rana, et al.
Publicado: (2018)

Mechanisms of relaxant activity of BAY 41-2272 in rat tracheal smooth muscle in vitro
por: Toque, Haroldo AF, et al.
Publicado: (2009)

Synergistic mutations in soluble guanylyl cyclase (sGC) reveal a key role for interfacial regions in the sGC activation mechanism
por: Childers, Kenneth C., et al.
Publicado: (2019)

Phosphodiesterases Regulate BAY 41-2272-Induced VASP Phosphorylation in Vascular Smooth Muscle Cells
por: Adderley, Shaquria P., et al.
Publicado: (2012)

BAY 41-2272 activates host defence against local and disseminated Candida albicans infections
por: Soeiro-Pereira, Paulo Vítor, et al.
Publicado: (2015)

The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes
por: Rosa, Irene, et al.
Publicado: (2022)

Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC
por: Becker-Pelster, Eva M., et al.
Publicado: (2022)

The soluble guanylyl cyclase activator BAY 60-2770 ameliorates detrusor dysfunction in obese mice
por: de Nucci, Gilberto, et al.
Publicado: (2013)

Nucleotidyl cyclase activity of recombinant soluble guanylyl cyclase
por: Rauch, Kerstin, et al.
Publicado: (2009)

Platelet inhibitory effects of the NO independent sGC stimulator riociguat (Bay 63-2561)
por: Reiss, Cora, et al.
Publicado: (2013)

The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective
por: Krishnan, Shalini M., et al.
Publicado: (2018)

Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy
por: Krishnan, Shalini Murali, et al.
Publicado: (2021)

Age, noise and cGMP: Pharmacological activation of soluble guanylyl cyclase (sGC) interacts with the progression of age related and noise induced hearing loss
por: Rüttiger, Lukas, et al.
Publicado: (2015)

Design, synthesis and biological evaluation of new 3,4-dihydroquinoxalin-2(1H)-one derivatives as soluble guanylyl cyclase (sGC) activators
por: Kintos, Dionysios-Panagiotis, et al.
Publicado: (2022)

Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator
por: Kolijn, Detmar, et al.
Publicado: (2020)

Activation of Haem-Oxidized Soluble Guanylyl Cyclase with BAY 60-2770 in Human Platelets Lead to Overstimulation of the Cyclic GMP Signaling Pathway
por: Mendes-Silverio, Camila B., et al.
Publicado: (2012)

The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms
por: Nelissen, Ellis, et al.
Publicado: (2022)

sGC redox regulation and asthma
por: Stuehr, Dennis J, et al.
Publicado: (2015)

Nucleotidyl Cyclase Activity of Particulate Guanylyl Cyclase A: Comparison with Particulate Guanylyl Cyclases E and F, Soluble Guanylyl Cyclase and Bacterial Adenylyl Cyclases Cyaa and Edema Factor
por: Beste, Kerstin Y., et al.
Publicado: (2013)

Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation
por: Lin, Eliane Q., et al.
Publicado: (2012)

Evidence for two catalytic centers and Mn(2+) as physiological cofactor of soluble guanylyl cyclase
por: Beste, Kerstin Yvonne, et al.
Publicado: (2011)

The role of particulate guanylyl cyclase B (GC-B) in auditory function in adult mice
por: Wolter, Steffen, et al.
Publicado: (2015)

Differential role of NO-sensitive guanylyl cyclase isoforms NO-GC1 and NO-GC2 in auditory function in adult mice
por: Möhrle, Dorit, et al.
Publicado: (2015)

Structural insights into sGC activation by different activators
por: van den Akker, Focco, et al.
Publicado: (2011)

Conjoined NO-sensitive guanylyl cyclases
por: Behrends, Sönke, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rs9u4fm5n5n042o5bq14sah3i7